Outset Medical CFO granted 71,630 RSUs

Gaeta Renee reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/29/2026 - 07:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Gaeta Renee reported acquisition or exercise transactions in this Form 4 filing.

Outset Medical, Inc.’s Chief Financial Officer, Renee Gaeta, reported a grant of 71,630 shares of common stock in the form of restricted stock units. The award was granted at no cash cost and raises her direct holdings to 185,383 shares after the transaction.

Each RSU represents the right to receive one share of common stock if it vests. The units vest 33.33% on June 26, 2027, with the remaining 66.67% vesting in equal quarterly installments over the following two years, as long as she remains in continuous service.

Insider Trade Summary

Grant/Award: 71,630 shares

Grant/Award 1 txn

Insider Gaeta Renee

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	71,630	$0.00	$0.00

Holdings After Transaction: Common Stock — 185,383 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSU") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Key Figures

RSUs granted: 71,630 units Grant price: $0.0000 per share Post-grant holdings: 185,383 shares +2 more

5 metrics

RSUs granted 71,630 units Restricted stock units granted on June 26, 2026

Grant price $0.0000 per share Transaction price per share for RSU grant

Post-grant holdings 185,383 shares Total shares held directly after the transaction

Initial vesting tranche 33.33% of RSUs Vests on June 26, 2027

Remaining vesting portion 66.67% of RSUs Vests quarterly over the following two years

Key Terms

restricted stock units ("RSU"), vesting, continuous service

3 terms

restricted stock units ("RSU") financial

"Represents restricted stock units ("RSU") granted to the reporting person on June 26, 2026."

vesting financial

"These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continuous service financial

"subject to the reporting person's continuous service through the applicable vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Outset Medical (OM) disclose in Renee Gaeta’s latest Form 4?

Outset Medical reported that CFO Renee Gaeta received 71,630 restricted stock units. These equity awards increase her direct holdings to 185,383 shares and are part of her compensation, subject to future vesting over a multi-year period tied to continued service.

How many RSUs did Outset Medical (OM) CFO Renee Gaeta receive?

Renee Gaeta received 71,630 restricted stock units. Each RSU represents a contingent right to one share of Outset Medical common stock, granted at no cash purchase price, and will convert into shares only as the vesting conditions are satisfied over time.

What is the vesting schedule for the OM CFO’s 71,630 RSUs?

The RSUs vest 33.33% on June 26, 2027. The remaining 66.67% vests in equal installments over the following two years on February 15, May 15, August 15, and November 15, provided Renee Gaeta remains in continuous service through each vesting date.

Did Outset Medical (OM) CFO pay cash for the 71,630 RSUs?

No cash was paid for these RSUs; the transaction price per share is reported as 0.0000. The grant functions as equity compensation, giving the CFO the right to receive common shares in the future if vesting and service conditions are met.

What are Renee Gaeta’s Outset Medical (OM) holdings after this RSU grant?

After the RSU grant, Renee Gaeta is reported to hold 185,383 shares of common stock directly. This figure reflects her position following the award and provides context for the relative size of the 71,630-unit grant within her total equity stake.

What conditions affect vesting of the OM CFO’s restricted stock units?

The RSUs require continuous service through each vesting date. If Renee Gaeta remains with Outset Medical through June 26, 2027 and subsequent quarterly dates, portions of the 71,630 units will convert into common shares according to the stated vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gaeta Renee

(Last) (First) (Middle)

3052 ORCHARD DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2026		A		71,630(1)	A	$0.0	185,383	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSU") granted to the reporting person on June 26, 2026. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on June 26, 2027, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

	John Brottem For: Renee Gaeta	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)